Recent Company News

• 08:09 AM ET Aug 14, 2026
  

  UK MHRA approves ROMVIMZA for adults with tenosynovial giant cell tumours (¥2430.0000, 0)

• 02:01 PM ET Aug 10, 2026
  

  StreetAccount Summary - Private Company Weekly Recap - Week of 3-Aug

• 07:06 AM ET Aug 06, 2026
  

  Ono Pharmaceutical enters into drug discovery partnership and option agreement with Mediar Therapeutics (¥2338.0000, 0)

• 11:05 PM ET Jul 30, 2026
  

  Ono Pharmaceutical reports Q1 net income attributable ¥24.15B vs FactSet ¥16.92B [2 est, ¥15.98-17.86B] (¥2363.0000, -94.5)

• 07:08 PM ET Jul 21, 2026
  

  President Trump states tariff on generic drugs will stay at 0% for 2 years then rise to 100% - Truth Social

• 10:36 PM ET Jul 16, 2026
  

  StreetAccount Summary - Trading higher/lower: Japan mid-day

• 09:25 PM ET Jul 08, 2026
  

  LigaChem Biosciences receives milestone payment for LCB97 from Ono Pharmaceutical; terms undisclosed (KRW 127600.0000, +7200)

• 02:54 AM ET Jun 19, 2026
  

  Ono Pharmaceutical upgraded to buy from neutral at Mizuho Securities (¥2249.0000, 0)

• 07:03 AM ET Jun 17, 2026
  

  Ono Pharmaceutical's Deciphera doses first patient in phase 3 INTREPID study of sapablursen for polycythemia vera (¥2249.5000, 0)

• 12:52 AM ET Jun 15, 2026
  

  Ono Pharmaceutical upgraded to outperform from neutral at Daiwa (¥2269.5000, +57)